A JAMA study found that low-value diagnostic tests are common in inpatient settings, and machine learning systems can be used to identify those tests and reduce their overutilization.
According to industry groups, some vendors are reporting providers have returned POC testing systems because the economics of using them no longer makes sense.
The service uses Hc1's machine learning technology to collect and analyze lab data, allowing systems to identify areas where usage is inappropriate or inefficient.
While microbiology has traditionally relied heavily on manual processes, most workflows can now be automated, and AI tools promise to streamline it further.
The company recently launched an automated microbiology system in its Marlborough, Massachusetts laboratory using instruments from automation firm COPAN.
The merger is aimed at expanding Salveo’s diagnostics capabilities and improving communication with providers and patients.
Revenues were $226.4 million, down from $263.7 million for the same quarter last year, but above the Wall Street estimate of $225.6 million.
As regulatory changes and technical advances reshape the clinical lab, directors are seeing a shift in responsibilities and the expertise required for the job.
A study by clinicians at St. Louis's Barnes-Jewish Hospital found that staff overrode alerts designed to warn of unnecessary lab testing roughly half the time.
The ruling overturned a lower court decision that blocked ACLA's suit challenging the data collection process used by CMS to set test prices under PAMA.
Much of the growth was driven by contributions from Genoptix, which NeoGenomics acquired in late 2018. Organically, revenues were up 20 percent.
LabCorp Diagnostics was down 2.8 percent, while Covance Drug Development was up 8 percent. The firm narrowed its revenue and earnings guidance for the year.
The first tests to be made available through the collaboration will be for Lyme disease and food sensitivity, leveraging PerkinElmer's expertise.
The lab beat the consensus Wall Street estimate on the top and bottom line, and maintained its revenue and adjusted EPS guidance for full-year 2019.
The letter supporting the LAB Act, which would delay reporting of lab payment data under PAMA, was submitted to the House Energy & Commerce Committee.
The ARUP COO recently published a commentary providing the clinical lab perspective on recent congressional proposals around LDT regulation.
Though the designation has seen slow uptake thus far, three tests received ADLT status in May, bringing the total number of approved ADLTs to five.
Quest will provide CHS of Long Island with lab testing as well as management of lab equipment, supplies, and procurement processes.
Clinical Pathology Laboratories said information on 2.2 million patients had been exposed in the same data breach that impacted millions of Quest and LabCorp patients.
Quest has made a strategic investment of an undisclosed amount in Sharecare, and Sharecare has named Quest its preferred laboratory partner.